Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Jan 11;25(1):25.
doi: 10.1186/s12871-025-02896-4.

Nebulized dexmedetomidine in the treatment of obstetric post-dural puncture headache: two case reports

Affiliations
Case Reports

Nebulized dexmedetomidine in the treatment of obstetric post-dural puncture headache: two case reports

Jeffrey Thomas et al. BMC Anesthesiol. .

Abstract

Post-dural puncture headache (PDPH) is a debilitating complication of neuraxial anesthesia, particularly prevalent in obstetric patients, usually characterized by a postural headache. PDPH is hypothesized to result from cerebrospinal fluid leakage through a dural puncture, triggering symptoms like neck stiffness and subjective hearing changes. While conservative measures are common for treatment, more refractory cases may require invasive interventions such as an epidural blood patch (EBP). Recent studies have shown promise in using nebulized dexmedetomidine (nDEX) for PDPH, offering a non-invasive alternative to EBP. Two case presentations illustrate the efficacy of nDEX in resolving PDPH symptoms rapidly and completely. These cases underscore the need for exploring novel therapeutic options, especially in obstetric patients where safe and prompt relief is essential for maternal and newborn well-being. While the EBP remains the gold standard, its limitations of accessibility and invasiveness highlight the significance of investigating alternatives like nDEX.

Keywords: Case report; Cesarean delivery; Dexmedetomidine; Neuraxial anesthesia; Obstetric anesthesia; Obstetric post-dural puncture headache (PDPH).

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: Consent was granted by the patients to write the case report. Ethics approval not applicable. Consent for publication: Informed written consent was granted by the patients to write the case report along with the publishing of the clinical details. Competing interests: The authors declare no competing interests. Author contributions: All of the authors (JT, LS, CM, PC, AS) made substantial contributions to the conception and design, or acquisition of data, or analysis and interpretation of data; they have been involved in drafting the manuscript or revising it critically for important intellectual content; have given final approval of the version to be published.

Similar articles

References

    1. Arnold M. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1–211. - PubMed
    1. Weinrich J, von Heymann C, Henkelmann A, Balzer F, Obbarius A, Ritschl PV, et al. Postdural puncture headache after neuraxial anesthesia: incidence and risk factors. Anaesthesist. 2020;69(12):878–85. - PMC - PubMed
    1. Kumar A, Sinha C, Anant M, Singh JK. Dexmedetomidine nebulization: an answer to post-dural puncture headache? Int J Obstet Anesth. 2019;40:155–6. - PubMed
    1. Mowafy SMS, Ellatif SEA. Effectiveness of nebulized dexmedetomidine for treatment of post-dural puncture headache in parturients undergoing elective cesarean section under spinal anesthesia: a randomized controlled study. J Anesth. 2021;35(4):515–24. - PubMed
    1. Goldszmidt E, Kern R, Chaput A, Macarthur A. The incidence and etiology of postpartum headaches: a prospective cohort study. Can J Anesth. 2005;52(9):971–7. - PubMed

Publication types

LinkOut - more resources